5 Feb 2024 • Most stroke survivors were able to safely take two types of common antidepressants, according to a preliminary study to be presented at the American Stroke Association’s International Stroke Conference 2024.

Ischemic stroke survivors, including those on anti-coagulation therapy, did not face an elevated risk of hemorrhagic stroke or serious bleeding events when using SSRIs or SNRIs.

However, combining antidepressants with DAPT increased the risk of bleeding. Antidepressants outside the SSRI/SNRI classes (mirtazapine, bupropion, tricyclics) raised the risk of serious bleeding events by 15% compared to SSRIs/SNRIs.

Source: AHA | Read full story